Proteomic identification of moesin upon exposure to acrolein

Abstract

Background: Acrolein (allyl Aldehyde) as one of smoke irritant exacerbates chronic airway diseases and increased in sputum of patients with asthma and chronic obstructive lung disease. But underlying mechanism remains unresolved. The aim of study was to identify protein expression in human lung microvascular endothelial cells (HMVEC-L) exposed to acrolein. Methods: A proteomic approach was used to determine the different expression of proteins at 8h and 24h after treatment of acrolein 30nM and 300nM to HMVEC-L. Treatment of HMVEC-L with acrolein 30nM and 300nM altered 21 protein spots on the two-dimensional gel, and these were then analyzed by MALDI-TOF MS. Results: These proteins included antioxidant, signal transduction, cytoskeleton, protein transduction, catalytic reduction. The proteins were classified into four groups according to the time course of their expression patterns such as continually increasing, transient increasing, transient decreasing, and continually decreasing. For validation immunohistochemical staining and Western blotting was performed on lung tissues from acrolein exposed mice. Moesin was expressed in endothelium, epithelium, and inflammatory cells and increased in lung tissues of acrolein exposed mice compared with sham treated mice. Conclusions: These results indicate that some of proteins may be an important role for airway disease exacerbation caused by acrolein exposure.